John Maciejowski

John Maciejowski

Auto-generated profile, based on publicly available information

John Maciejowski

Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2017 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
JMJohn Maciejowski
John Maciejowski
TLTitia de Lange
Titia de Lange

1 December 2015 in Cell
Verified
Journal Article
Closed access
JMJohn Maciejowski
John Maciejowski
YLYilong Li
Yilong Li
NBNazario Bosco
Nazario Bosco
PCPeter J. Campbell
Peter J. Campbell
TLTitia de Lange
Titia de Lange

20 July 2022 in Nature
Verified
Journal Article
Open access
PDF file
MPMia Petljak
Mia Petljak
ADAlexandra Dananberg
Alexandra Dananberg
KCKevan Chu
Kevan Chu
EBErik N. Bergstrom
Erik N. Bergstrom
JSJosefine Striepen
Josefine Striepen
JMJohn Maciejowski
John Maciejowski
The APOBEC3 family of cytosine deaminases has been implicated in some of the most prevalent mutational signatures in cancer1–3. However, a causal link between endogenous APOBEC3 enzymes and mutational signatures in human cancer genomes has not been established, leaving the mechanisms of APOBEC3 mutagenesis poorly understood. Here, to investigate the mechanisms of APOBEC3 mutagenesis, we deleted implicated genes from human cancer cell lines that naturally generate APOBEC3-associated mutational signatures over time4. Analysis of non-clustered and clustered signatures across whole-genome sequences from 251 breast, bladder and lymphoma cancer cell line clones revealed that APOBEC3A deletion diminished APOBEC3-associated mutational signatures. Deletion of both APOBEC3A and APOBEC3B further decreased APOBEC3 mutation burdens, without eliminating them. Deletion of APOBEC3B increased APOBEC3A protein levels, activity and APOBEC3A-mediated mutagenesis in some cell lines. The uracil glycosylase UNG was required for APOBEC3-mediated transversions, whereas the loss of the translesion polymerase REV1 decreased overall mutation burdens. Together, these data represent direct evidence that endogenous APOBEC3 deaminases generate prevalent mutational signatures in human cancer cells. Our results identify APOBEC3A as the main driver of these mutations, indicate that APOBEC3B can restrain APOBEC3A-dependent mutagenesis while contributing its own smaller mutation burdens and dissect mechanisms that translate APOBEC3 activities into distinct mutational signatures.

1 October 2020 in Cell
Verified
Journal Article
Closed access
KHKevin Hadi
Kevin Hadi
XYXiaotong Yao
Xiaotong Yao
JBJulie M. Behr
Julie M. Behr
ADAditya Deshpande
Aditya Deshpande
CXCharalampos Xanthopoulakis
Charalampos Xanthopoulakis
MIMarcin Imielinski
Marcin Imielinski

20 January 2021 in Molecular Cell
Verified
Journal Article
Closed access
LMLisa Mohr
Lisa Mohr
ETEléonore Toufektchan
Eléonore Toufektchan
PMPatrick von Morgen
Patrick von Morgen
KCKevan Chu
Kevan Chu
AKAakanksha Rajiv Kapoor
Aakanksha Rajiv Kapoor
JMJohn Maciejowski
John Maciejowski

1 February 2014 in Cell
Verified
Journal Article
Closed access
VRVeronica Rodriguez-Bravo
Veronica Rodriguez-Bravo
JMJohn Maciejowski
John Maciejowski
JCJennifer Corona
Jennifer Corona
HBHåkon Kirkeby Buch
Håkon Kirkeby Buch
PCPhilippe Collin
Philippe Collin
PJPrasad V. Jallepalli
Prasad V. Jallepalli